Arrow Generics, a Watson Company, launches Naratriptan Tablets, the second day 1 launch in a week!
Posted on 10th Mar 2012
Arrow Generics, a Watson Company are very proud to announce the launch of Naratriptan 2.5mg Tablets, available in packs of 6 and 12.
Naratriptan is the generic version of Naramig® and is indicated for the acute treatment of migraine attacks with or without aura.
This launch marks the 4th consecutive Patent Expiry launch for Arrow. Previous day 1 launches in 2012 include Latanoprost, Donepezil and Zolmitriptan.
If you require further information please contact us via the web page.